(41 days)
K933971/S1
K-ASSAY Immunoglobulin A assay on the Hitachi 717 Analyzer
No
The device description and performance studies focus on a standard in vitro diagnostic assay using turbidity measurements, with no mention of AI or ML techniques.
No This device is an in vitro diagnostic assay used for the quantitative determination of immunoglobulin A in human serum or plasma to aid in diagnosis, not for treatment.
Yes
The "Intended Use / Indications for Use" section explicitly states that the assay "aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents."
No
The device description clearly states it is an "in vitro diagnostic assay" that measures light scattering (turbidity) at 700 nm, indicating it is a physical assay requiring reagents and a measurement instrument, not solely software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the assay is used for the "quantitation of immunoglobulin A in human serum or plasma" and "aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents." This clearly indicates a diagnostic purpose using samples from the human body.
- Device Description: The "Device Description" further confirms this by stating it is an "in vitro diagnostic assay for the quantitative determination of immunoglobulin A in human serum or plasma." It describes the mechanism of action which involves testing a biological sample (serum or plasma) outside of the body ("in vitro").
- Performance Studies: The performance studies describe testing with control materials and comparing results to a predicate device, which is standard practice for validating IVD performance.
- Predicate Device: The mention of a "Predicate Device(s)" with a K number (K933971/S1) is a strong indicator that this device is being submitted for regulatory clearance as an IVD, as predicate devices are used for demonstrating substantial equivalence to legally marketed IVDs.
All of these points align with the definition and characteristics of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Immunoglobulin A assay is used for the quantitation of immunoglobulin A in human serum or plasma. Measurement of immunoglobulin A aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents.
Product codes
CZP
Device Description
Immunoglobulin A is an in vitro diagnostic assay for the quantitative determination of immunoglobulin A in human serum or plasma. Antigen in the sample bonds to the specific antibody in the reagent, forming an immune complex. The immune complex causes an increase in light scattering, measured by reading turbidity at 700 nm, which correlates with the concentration of immunoglobulin A in the sample.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Comparative performance studies were conducted using the AEROSET™ System. The Immunoglobulin A assay method comparison yielded acceptable correlation with the K-ASSAY Immunoglobulin A assay on the Hitachi 717 Analyzer. The correlation coefficient = 0.9879, slope = 1.006, and the Y-intercept = -0.404 mg/dL. Precision studies were conducted using the Immunoglobulin A assay. Within-run, between-run, and between-day studies were performed using two levels of control material. The total %CV for Level 1/Panel 401 is 1.5% and Level 2/Panel 402 is 2.4%. The Immunoglobulin A assay range is 0.566 to 797.44 mg/dL. The limit of quantitation (sensitivity) of the Immunoglobulin A assay is 0.566 mg/dL. These data demonstrate that the performance of the Immunoglobulin A assay is substantially equivalent to the performance of the K-ASSAY Immunoglobulin A assay on the Hitachi 717 Analyzer.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
The correlation coefficient = 0.9879, slope = 1.006, and the Y-intercept = -0.404 mg/dL. The total %CV for Level 1/Panel 401 is 1.5% and Level 2/Panel 402 is 2.4%. The Immunoglobulin A assay range is 0.566 to 797.44 mg/dL. The limit of quantitation (sensitivity) of the Immunoglobulin A assay is 0.566 mg/dL.
Predicate Device(s)
K933971/S1
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 866.5510 Immunoglobulins A, G, M, D, and E immunological test system.
(a)
Identification. An immunoglobulins A, G, M, D, and E immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the immunoglobulins A, G, M, D, an E (serum antibodies) in serum. Measurement of these immunoglobulins aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents.(b)
Classification. Class II (performance standards).
0
510(k) Summary
Submitter's Name/Address
Abbott Laboratories 1920 Hurd Drive Irving, Texas 75038
NOV
4 1998
Contact Person Linda Morris Senior Regulatory Specialist MS 1-8 Regulatory Affairs (972) 518-6711 Fax (972) 753-3367
| Date of Preparation of this Summary: | September 23, 1998 |
|---|---|
| Device Trade or Proprietary Name: | IgA |
| Device Common/Usual Name or Classification Name: | Immunoglobulin A |
| Classification Number/Class: | Class II |
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is: K98.3359
Test Description:
Immunoglobulin A is an in vitro diagnostic assay for the quantitative determination of immunoglobulin A in human serum or plasma. Antigen in the sample bonds to the specific antibody in the reagent, forming an immune complex. The immune complex causes an increase in light scattering, measured by reading turbidity at 700 nm, which correlates with the concentration of immunoglobulin A in the sample.
Substantial Equivalence:
The Immunoglobulin A assay is substantially equivalent to the K-ASSA Y® Immunoglobulin A assay (K933971/S1) on the Hitachi® 717 Analyzer.
Immunoglobulin A 510(k) September 23, 1998 IgA 5 VI lwp
Section II Page 1
00000011
1
Both assays yield similar Performance Characteristics. Similarities:
- . Both assays are in vitro immunoassays.
- Both assays can be used for the quantitative determination of . immunoglobulin A.
- Both assays yield similar clinical results. .
- Both assays are based on the light scattering properties of antigen-antibody . complexes.
Differences:
- There is a difference between the assay range. .
Intended Use:
The Immunoglobulin A assay is used for the quantitation of immunoglobulin A in human serum or plasma.
Performance Characteristics:
Comparative performance studies were conducted using the AEROSET™ System. The Immunoglobulin A assay method comparison yielded acceptable correlation with the K-ASSAY Immunoglobulin A assay on the Hitachi 717 Analyzer. The correlation coefficient = 0.9879, slope = 1.006, and the Y-intercept = -0.404 mg/dL. Precision studies were conducted using the Immunoglobulin A assay. Within-run, between-run, and between-day studies were performed using two levels of control material. The total %CV for Level 1/Panel 401 is 1.5% and Level 2/Panel 402 is 2.4%. The Immunoglobulin A assay range is 0.566 to 797.44 mg/dL. The limit of quantitation (sensitivity) of the Immunoglobulin A assay is 0.566 mg/dL. These data demonstrate that the performance of the Immunoglobulin A assay is substantially equivalent to the performance of the K-ASSAY Immunoglobulin A assay on the Hitachi 717 Analyzer.
Section II Page 2
0000012
2
Conclusion:
The Immunoglobulin A assay is substantially equivalent to the K-ASSAY Immunoglobulin A assay on the Hitachi 717 Analyzer as demonstrated by results obtained in the studies.
Immunoglobulin A 510(k) September 23, 1998
IgA_5_V1.lwp
Section II Page 3
Image /page/2/Picture/4 description: The image shows the number 0000013 in a bold, sans-serif font. The numbers are black against a white background. The number is likely a serial number or some other type of identification number.
3
Image /page/3/Picture/1 description: The image contains the words "Public Health Service". The text is in a simple, sans-serif font. The words are stacked on top of each other, with "Public Health" on the top line and "Service" on the bottom line.
Image /page/3/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.
NOV
Ms. Linda Morris Senior Requlatory Specialist MS 1-8 Regulatory Affairs Abbott Laboratories 1920 Hurd Drive Irving, Texas 75038
K983359 Re: Trade Name: IqA Regulatory Class: II Product Code: CZP Dated: September 23, 1998 Received: September 24, 1998
Dear Ms. Morris:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice reguirements, as set forth in the Quality System Requlation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obliqation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
4
Page 2
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbrandinq by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Steven Butman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known): K98 3359
Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications For Use:
The Immunoglobulin A assay is used for the quantitation of immunoglobulin A in human serum or plasma. Measurement of immunoglobulin A aids in the diagnosis of abnormal protein metabolism and the body's lack of ability to resist infectious agents.
Peter E. Maher
al Laboratory De
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use OR Over-The-Counter Use (Per 21 CFR 801.109)
(Optional Format 1-2-96)
00000006
Immunoglobulin A 510(k) September 23, 1998 lyA_5_V1.lwp